Pemetrexed plus cisplatin in patients with previously treated advanced sarcoma: a multicenter, single-arm, phase II trial.

ESMO Open · 2021 · PMC8424216 · PMID 34482181

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Although it did not reach statistical significance due to the small sample size, 100% of undifferentiated pleomorphic sarcoma showed low TS and ERCC1 expression, and 100% of synovial sarcoma and MPNST showed high TS and ERCC1 expression.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.